Phase I Malaria Vaccine Trial with a Long Synthetic Peptide Derived from the Merozoite Surface Protein 3 Antigen

The C-terminal conserved region of Plasmodium falciparum merozoite surface protein 3 (MSP3) is the trigger antigen of a protective immune response mediated by cytophilic antibodies. In an open, randomized, two-adjuvant (Montanide ISA 720, aluminum hydroxide) phase I clinical trial we evaluated the s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Audran, Régine, Cachat, Michel, Lurati, Floriana, Soe, Soe, Leroy, Odile, Corradin, Giampietro, Druilhe, Pierre, Spertini, François
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2005
Assuntos:
Microbial Immunity and Vaccines
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1307056/
https://ncbi.nlm.nih.gov/pubmed/16299295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/IAI.73.12.8017-8026.2005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados